Oral communication in the Fetal Medicine Foundation World Congress, june 2013. Description of the results in our hospital after 20 years of selective embryo-fetal reduction. Factors affecting outcome.
This document discusses techniques for multifetal pregnancy reduction (MFPR) without using potassium chloride (KCl), a cardiotoxic agent. It summarizes a study of 51 women with triplet or higher-order pregnancies who underwent MFPR using intracardiac puncture and aspiration until asystole was confirmed, without KCl. The technique resulted in an abortion rate of 7.8%, with most deliveries (80%) occurring after 34 weeks gestation. The average birth weight was 2.3kg. The study suggests MFPR without KCl has better outcomes than techniques using KCl, with lower rates of preterm birth and abortion. The conclusion is that MFPR should be offered to women with high-
Multifetal pregnancies, especially those of higher order multiples, pose significant risks to both mother and fetuses. These risks include maternal complications such as preeclampsia and gestational diabetes as well as fetal complications like premature birth, low birth weight, and developmental impairments. Multifetal pregnancy reduction (MFPR) aims to reduce these risks by terminating one or more fetuses, leaving the remaining fetuses with improved health outcomes. While controversial, MFPR is generally considered ethically acceptable for reducing high order multiples and may provide benefits for triplet pregnancies. The procedure involves using ultrasound guidance to transvaginally inject a needle into the selected fetus between 7-12 weeks gestation.
Ovulation Induction Protocols in Endometriosis - Dr. Abayomi Ajayiabayomi ajayi
This document discusses ovulation induction protocols for endometriosis. It notes that 30-50% of infertility cases involve endometriosis. While natural fertility is reduced for women with endometriosis, IVF is the most effective treatment for overcoming endometriosis-related infertility. However, endometriosis impacts IVF outcomes by requiring higher gonadotropin doses and longer stimulation, producing fewer and lower quality eggs and embryos, and resulting in lower success rates. The document reviews various stimulation protocols and other measures that aim to improve IVF pregnancy rates for women with endometriosis, but notes there is no consensus on the best approach.
Challenges - In management of infertilityDrRokeyaBegum
Over fertility is a problem of Bangladesh.Still infertility is an issue 1 in 7 couples have difficulties to conceive.
Inability to create a desired pregnancy that culminates in the Birth of child is likely to create a life crisis for women and their partners.
Hysteroscopic surgery can effectively treat various intrauterine pathologies that cause infertility such as polyps, fibroids, adhesions, and septums. It allows for direct visualization and removal of abnormalities, improving chances for spontaneous or assisted conception. While hysteroscopy is considered the gold standard for diagnosing intrauterine issues, less invasive methods like ultrasound and HSG are usually sufficient. Routine hysteroscopy before first IVF is not recommended as it does not improve live birth rates, but may be beneficial after repeated failures. Operative hysteroscopy can significantly enhance fertility outcomes.
Uterus (womb) as an organ is pivotal not only to giving birth, but also to the overall well-being of women and their physical, emotional, and sexual health.
This document discusses fertility preservation techniques. It begins by defining ovarian reserve and discussing age-related declines in fertility. It describes medical indications for fertility preservation in cancer patients, including for both pre-pubertal and post-pubertal individuals. For pre-pubertal patients, options include ovarian tissue cryopreservation while for post-pubertal patients options are oocyte and embryo cryopreservation. The document also discusses the use of GnRH analogs to protect ovarian reserve during cancer treatment and debates the ethics of fertility preservation for social reasons like career planning. It concludes by looking to future techniques like in vitro maturation of oocytes.
The document discusses the post coital test (PCT), which examines cervical mucus after intercourse for the presence of sperm. While the value of the PCT is debated, it provides information on estrogen stimulation, adequacy of insemination, and how sperm interact with cervical secretions. The document reviews procedures for administering the PCT and interpreting results, noting disagreement around methods and criteria. Some studies found higher pregnancy rates with positive versus negative PCT results, suggesting a positive PCT may increase chances of spontaneous pregnancy.
This document discusses techniques for multifetal pregnancy reduction (MFPR) without using potassium chloride (KCl), a cardiotoxic agent. It summarizes a study of 51 women with triplet or higher-order pregnancies who underwent MFPR using intracardiac puncture and aspiration until asystole was confirmed, without KCl. The technique resulted in an abortion rate of 7.8%, with most deliveries (80%) occurring after 34 weeks gestation. The average birth weight was 2.3kg. The study suggests MFPR without KCl has better outcomes than techniques using KCl, with lower rates of preterm birth and abortion. The conclusion is that MFPR should be offered to women with high-
Multifetal pregnancies, especially those of higher order multiples, pose significant risks to both mother and fetuses. These risks include maternal complications such as preeclampsia and gestational diabetes as well as fetal complications like premature birth, low birth weight, and developmental impairments. Multifetal pregnancy reduction (MFPR) aims to reduce these risks by terminating one or more fetuses, leaving the remaining fetuses with improved health outcomes. While controversial, MFPR is generally considered ethically acceptable for reducing high order multiples and may provide benefits for triplet pregnancies. The procedure involves using ultrasound guidance to transvaginally inject a needle into the selected fetus between 7-12 weeks gestation.
Ovulation Induction Protocols in Endometriosis - Dr. Abayomi Ajayiabayomi ajayi
This document discusses ovulation induction protocols for endometriosis. It notes that 30-50% of infertility cases involve endometriosis. While natural fertility is reduced for women with endometriosis, IVF is the most effective treatment for overcoming endometriosis-related infertility. However, endometriosis impacts IVF outcomes by requiring higher gonadotropin doses and longer stimulation, producing fewer and lower quality eggs and embryos, and resulting in lower success rates. The document reviews various stimulation protocols and other measures that aim to improve IVF pregnancy rates for women with endometriosis, but notes there is no consensus on the best approach.
Challenges - In management of infertilityDrRokeyaBegum
Over fertility is a problem of Bangladesh.Still infertility is an issue 1 in 7 couples have difficulties to conceive.
Inability to create a desired pregnancy that culminates in the Birth of child is likely to create a life crisis for women and their partners.
Hysteroscopic surgery can effectively treat various intrauterine pathologies that cause infertility such as polyps, fibroids, adhesions, and septums. It allows for direct visualization and removal of abnormalities, improving chances for spontaneous or assisted conception. While hysteroscopy is considered the gold standard for diagnosing intrauterine issues, less invasive methods like ultrasound and HSG are usually sufficient. Routine hysteroscopy before first IVF is not recommended as it does not improve live birth rates, but may be beneficial after repeated failures. Operative hysteroscopy can significantly enhance fertility outcomes.
Uterus (womb) as an organ is pivotal not only to giving birth, but also to the overall well-being of women and their physical, emotional, and sexual health.
This document discusses fertility preservation techniques. It begins by defining ovarian reserve and discussing age-related declines in fertility. It describes medical indications for fertility preservation in cancer patients, including for both pre-pubertal and post-pubertal individuals. For pre-pubertal patients, options include ovarian tissue cryopreservation while for post-pubertal patients options are oocyte and embryo cryopreservation. The document also discusses the use of GnRH analogs to protect ovarian reserve during cancer treatment and debates the ethics of fertility preservation for social reasons like career planning. It concludes by looking to future techniques like in vitro maturation of oocytes.
The document discusses the post coital test (PCT), which examines cervical mucus after intercourse for the presence of sperm. While the value of the PCT is debated, it provides information on estrogen stimulation, adequacy of insemination, and how sperm interact with cervical secretions. The document reviews procedures for administering the PCT and interpreting results, noting disagreement around methods and criteria. Some studies found higher pregnancy rates with positive versus negative PCT results, suggesting a positive PCT may increase chances of spontaneous pregnancy.
Predictive Factors influencing pregnancy rate after intrauterine inseminationDrRokeyaBegum
Intrauterine insemination (IUI) is an assisted reproduction procedure that involves the deposition of a processed semen sample in the upper uterine cavity.This is non invasive and cost effective first line therapy for infertile couple.IUI can be done easily in simple setups.
Selection of an embryo from a large number of embryos and then placing it to the uterus is known as selective embryo transfer. This fertility preservation process is usually done after the process of IVF cycle and cancels the risks of spontaneous transfer of multiple embryos. Have a look at the detailed description of elective single embryo transfer in the following ppt.
- There is consensus that submucosal fibroids interfere with fertility and should be removed in infertile patients, regardless of size or symptoms. Subserosal fibroids do not impact fertility.
- The impact of intramural fibroids on fertility is still uncertain. Some studies show they may reduce clinical pregnancy and increase miscarriage rates, while other studies show no effect.
- The benefits of myomectomy for interstitial or intramural fibroids are unclear, as evidence is limited and conflicting. Myomectomy may be considered for failed IVF cycles or large fibroids distorting the cavity.
- There are ongoing controversies around the impact of fibroid number, location and size,
- The document discusses fertility outcomes after ectopic pregnancy and various treatment options.
- Fertility rates after ectopic pregnancy are around 60% for subsequent intrauterine pregnancy and 28% risk of recurrent ectopic pregnancy, regardless of treatment.
- Expectant management, methotrexate treatment, and surgery all have comparable fertility outcomes, with subsequent intrauterine pregnancy rates around 60-70% within 2 years. The risk of recurrent ectopic pregnancy is also similar between treatments.
This document discusses how evidence-based medicine is changing attitudes in gynecologic practice. It provides an example of a randomized controlled trial comparing two ovarian induction protocols for intrauterine insemination. The trial found that using clomiphene citrate along with human menopausal gonadotropin reduced the rate of premature luteinizing hormone surges compared to human menopausal gonadotropin alone, with no significant differences in clinical pregnancy rates. The document outlines how evidence from randomized trials, prognostic models, economic analyses and other studies can inform clinical decision-making and change practices in gynecology.
Endometrioma and how it affects IVF outcome : modified procedure with encoura...Mohamed Walaa El Deeb
1) Endometriomas are common in women with endometriosis and infertility, affecting up to 50% of subfertile women. Surgical removal carries risks of reducing ovarian reserve.
2) A meta-analysis found no significant difference in ovarian response or pregnancy rates between surgery vs no treatment prior to IVF. However, large endometriomas over 4cm may interfere with oocyte retrieval.
3) The authors propose a modified aspiration technique for large, recurrent endometriomas as an alternative to repeated surgery. Preliminary results show encouraging pregnancy rates without complications. Larger studies are still needed.
There is a recent and strong trend in western countries to advocate single embryo transfer (eSET). The rational behind this trend is to avoid complications of multiple pregnancy after IVF. However, we would urgue that twin pregnancy is totally different from high order multiple pregnancy and the long term economic analysis of twin pregnancy has never been explored before. We tried to calculate the risks and benefits of twin pregnancy from a society perspectives. Based on our model, it seems that double embryo transfer (DET) is still a valid option.
This document discusses the use of letrozole for fertility treatments. It begins with an introduction and outline on polycystic ovary syndrome (PCOS), unexplained infertility, fertility preservation for breast cancer patients, frozen embryo transfer, and decreasing ovarian hyperstimulation syndrome (OHSS). It then goes into more detail on each topic, providing evidence from randomized controlled trials, meta-analyses, and clinical guidelines that letrozole results in higher pregnancy and live birth rates compared to clomiphene citrate for PCOS and unexplained infertility. It also discusses how letrozole can be used during fertility preservation for breast cancer patients to prevent high estrogen levels. The document concludes by stating letrozole may
This document discusses changing concepts in ectopic pregnancy. It notes that over 95% of ectopic pregnancies are tubal, and risk factors include previous tubal surgery or pathology. Early diagnosis has increased due to improved ultrasound technology. Most ectopic pregnancies can now be treated medically with methotrexate rather than surgically. Transvaginal ultrasound and serum hCG levels are used for diagnosis. Medical treatment is now often preferred over surgical treatment.
This document discusses the pros and cons of transferring embryos on day 5 (blastocyst stage) versus day 3. It raises questions about whether day 5 transfer should be routine practice and whether there are any adverse effects. Specifically, it notes that day 5 transfer is not suitable for all women, especially those with a limited number of embryos, and that an increased incidence of autism has been reported. It also discusses whether day 5 transfer is practical given the infrastructure needed, and whether it is really of any value if more than one embryo is being transferred. The conclusion is that day 5 transfer should only be offered for highly selected cases.
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayiabayomi ajayi
The document discusses the role of endoscopy in treating infertility. It notes that many causes of female infertility, such as tubal factors, endometriosis, and uterine fibroids, can be diagnosed and treated using endoscopic procedures like laparoscopy and hysteroscopy. The document outlines benefits of endoscopy like less invasive surgery, quick recovery, and improved chances of pregnancy. However, it also notes challenges like limited availability, costs, and need for more physician training in endoscopic procedures.
How to choose between drugs: efficacy / safety and cost effectiveness. In IVF, we have GnRHagonist and antagonists: how to choose based on best available evidence. This talk may help to answer this question
Invited lecture by Dr Sujoy dasgupta in the Annual Conference of the "Academy of Clinical Embryologists" (ACE) held in October 2021 in "Hybrid mode" (Kolkata and Webinar)
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayiabayomi ajayi
This document discusses methods for final oocyte maturation in IVF treatment. It notes that human chorionic gonadotropin (HCG) has traditionally been used but gonadotropin-releasing hormone (GnRH) agonists can also be used to reduce the risk of ovarian hyperstimulation syndrome (OHSS). While GnRH agonists prevent OHSS, they are associated with lower pregnancy rates. However, combining a GnRH agonist trigger with low-dose HCG or vitrification of all embryos may optimize pregnancy rates while still preventing OHSS. The optimal luteal phase support when using a GnRH agonist trigger remains an area of ongoing research.
Doctor, will I be able to have a baby ? Fertility after cancer Dr Aniruddha Malpani
This document discusses fertility preservation options for cancer patients. It notes that chemotherapy and radiation can damage fertility, but fertility preservation techniques exist to help mitigate this, including freezing eggs, sperm, ovarian tissue or testicular tissue. It recommends that oncologists discuss these options proactively with patients to give them hope for biological children after cancer. Specific techniques are described such as in vitro fertilization with eggs or sperm frozen before treatment. Referral to fertility specialists is advised so patients can explore preservation options before starting cancer treatment.
The Role of laparoscopy in the era of ARTDrRokeyaBegum
The advancement of new perspectives in assisted reproductive technology (ART) through the use of modern infertility evaluation technique Stillclinician needs to reassess how infertility should be best treated.
Recently the focus of treatment for infertility has shifted from systematic correction of each identified factor.
May occur very early on during the attachment or migration stages (No objective evidence e.g. –ve hCG)
May also occur at a later stage (+ve hCG) but process becomes disrupted
Definition: Refers to the failure of the embryo to reach a stage when an intrauterine gestational sac is recognized by ultrasonography.
Implantation failure can apply to patients undergoing ART and patients trying to conceive without any fertility treatment.
It is a separate entity from RPL
Orvieto et al - 3 failed IVF-ET cycles with good quality embryos transferred .
Zeyneloglu et al. - 3 unsuccessful IVF specifically with two embryos of high quality
Simon and Laufer - embryo & endometrium can both play an active role in RIF
Coughlan et al. suggest a more complete working definition taking into account maternal age, number of embryos transferred, and number of cycles completed.
They define RIF as the failure of clinical pregnancy after 4 good quality embryo transfers, with at least three fresh or frozen IVF cycles, and in women under the age of 40
RIF is a complex problem with a wide variety of etiologies / mechanisms/ treatment options.
Recommendations vary depending on the source of their problem. Perhaps the best and yet most complex answer is personalized medicine, a personal approach to each patient depending on her unique set of characteristics.
It would help to establish a set of standardized tests to use, in order to do a preliminary evaluation on each patient, which would then hopefully direct the approach of treatment for each individual couple.
This can be implemented when we have well designed studies that will help us to establish new protocols.
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIDR SHASHWAT JANI
This document discusses the role of progesterone in preventing preterm labor and delivery. It provides information on progesterone's mechanisms of action, guidelines and evidence for its use, and summarizes various studies conducted on oral and vaginal progesterone for reducing preterm birth risks in high-risk groups like women with a short cervix or history of prior preterm delivery. The document also compares micronized progesterone to hydroxyprogesterone caproate in terms of indications and side effects.
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...Apollo Hospitals
The incidence of multiple gestations is increasing with
increasing maternal age and use of assisted reproduction
techniques. Selective fetal reduction of multifetal pregnancies is now widely practiced to reduce the higher order multiples to twins based on evidence from nonrandomised studies which suggests that this will improve the perinatal outcome. The proportion of twin pregnancies with unique fetal and maternal problems is therefore increasing. Optimising maternal, fetal and perinatal outcomes in twin pregnancies continues to be a formidable challenge in the present day clinical practice.
Predictive Factors influencing pregnancy rate after intrauterine inseminationDrRokeyaBegum
Intrauterine insemination (IUI) is an assisted reproduction procedure that involves the deposition of a processed semen sample in the upper uterine cavity.This is non invasive and cost effective first line therapy for infertile couple.IUI can be done easily in simple setups.
Selection of an embryo from a large number of embryos and then placing it to the uterus is known as selective embryo transfer. This fertility preservation process is usually done after the process of IVF cycle and cancels the risks of spontaneous transfer of multiple embryos. Have a look at the detailed description of elective single embryo transfer in the following ppt.
- There is consensus that submucosal fibroids interfere with fertility and should be removed in infertile patients, regardless of size or symptoms. Subserosal fibroids do not impact fertility.
- The impact of intramural fibroids on fertility is still uncertain. Some studies show they may reduce clinical pregnancy and increase miscarriage rates, while other studies show no effect.
- The benefits of myomectomy for interstitial or intramural fibroids are unclear, as evidence is limited and conflicting. Myomectomy may be considered for failed IVF cycles or large fibroids distorting the cavity.
- There are ongoing controversies around the impact of fibroid number, location and size,
- The document discusses fertility outcomes after ectopic pregnancy and various treatment options.
- Fertility rates after ectopic pregnancy are around 60% for subsequent intrauterine pregnancy and 28% risk of recurrent ectopic pregnancy, regardless of treatment.
- Expectant management, methotrexate treatment, and surgery all have comparable fertility outcomes, with subsequent intrauterine pregnancy rates around 60-70% within 2 years. The risk of recurrent ectopic pregnancy is also similar between treatments.
This document discusses how evidence-based medicine is changing attitudes in gynecologic practice. It provides an example of a randomized controlled trial comparing two ovarian induction protocols for intrauterine insemination. The trial found that using clomiphene citrate along with human menopausal gonadotropin reduced the rate of premature luteinizing hormone surges compared to human menopausal gonadotropin alone, with no significant differences in clinical pregnancy rates. The document outlines how evidence from randomized trials, prognostic models, economic analyses and other studies can inform clinical decision-making and change practices in gynecology.
Endometrioma and how it affects IVF outcome : modified procedure with encoura...Mohamed Walaa El Deeb
1) Endometriomas are common in women with endometriosis and infertility, affecting up to 50% of subfertile women. Surgical removal carries risks of reducing ovarian reserve.
2) A meta-analysis found no significant difference in ovarian response or pregnancy rates between surgery vs no treatment prior to IVF. However, large endometriomas over 4cm may interfere with oocyte retrieval.
3) The authors propose a modified aspiration technique for large, recurrent endometriomas as an alternative to repeated surgery. Preliminary results show encouraging pregnancy rates without complications. Larger studies are still needed.
There is a recent and strong trend in western countries to advocate single embryo transfer (eSET). The rational behind this trend is to avoid complications of multiple pregnancy after IVF. However, we would urgue that twin pregnancy is totally different from high order multiple pregnancy and the long term economic analysis of twin pregnancy has never been explored before. We tried to calculate the risks and benefits of twin pregnancy from a society perspectives. Based on our model, it seems that double embryo transfer (DET) is still a valid option.
This document discusses the use of letrozole for fertility treatments. It begins with an introduction and outline on polycystic ovary syndrome (PCOS), unexplained infertility, fertility preservation for breast cancer patients, frozen embryo transfer, and decreasing ovarian hyperstimulation syndrome (OHSS). It then goes into more detail on each topic, providing evidence from randomized controlled trials, meta-analyses, and clinical guidelines that letrozole results in higher pregnancy and live birth rates compared to clomiphene citrate for PCOS and unexplained infertility. It also discusses how letrozole can be used during fertility preservation for breast cancer patients to prevent high estrogen levels. The document concludes by stating letrozole may
This document discusses changing concepts in ectopic pregnancy. It notes that over 95% of ectopic pregnancies are tubal, and risk factors include previous tubal surgery or pathology. Early diagnosis has increased due to improved ultrasound technology. Most ectopic pregnancies can now be treated medically with methotrexate rather than surgically. Transvaginal ultrasound and serum hCG levels are used for diagnosis. Medical treatment is now often preferred over surgical treatment.
This document discusses the pros and cons of transferring embryos on day 5 (blastocyst stage) versus day 3. It raises questions about whether day 5 transfer should be routine practice and whether there are any adverse effects. Specifically, it notes that day 5 transfer is not suitable for all women, especially those with a limited number of embryos, and that an increased incidence of autism has been reported. It also discusses whether day 5 transfer is practical given the infrastructure needed, and whether it is really of any value if more than one embryo is being transferred. The conclusion is that day 5 transfer should only be offered for highly selected cases.
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayiabayomi ajayi
The document discusses the role of endoscopy in treating infertility. It notes that many causes of female infertility, such as tubal factors, endometriosis, and uterine fibroids, can be diagnosed and treated using endoscopic procedures like laparoscopy and hysteroscopy. The document outlines benefits of endoscopy like less invasive surgery, quick recovery, and improved chances of pregnancy. However, it also notes challenges like limited availability, costs, and need for more physician training in endoscopic procedures.
How to choose between drugs: efficacy / safety and cost effectiveness. In IVF, we have GnRHagonist and antagonists: how to choose based on best available evidence. This talk may help to answer this question
Invited lecture by Dr Sujoy dasgupta in the Annual Conference of the "Academy of Clinical Embryologists" (ACE) held in October 2021 in "Hybrid mode" (Kolkata and Webinar)
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayiabayomi ajayi
This document discusses methods for final oocyte maturation in IVF treatment. It notes that human chorionic gonadotropin (HCG) has traditionally been used but gonadotropin-releasing hormone (GnRH) agonists can also be used to reduce the risk of ovarian hyperstimulation syndrome (OHSS). While GnRH agonists prevent OHSS, they are associated with lower pregnancy rates. However, combining a GnRH agonist trigger with low-dose HCG or vitrification of all embryos may optimize pregnancy rates while still preventing OHSS. The optimal luteal phase support when using a GnRH agonist trigger remains an area of ongoing research.
Doctor, will I be able to have a baby ? Fertility after cancer Dr Aniruddha Malpani
This document discusses fertility preservation options for cancer patients. It notes that chemotherapy and radiation can damage fertility, but fertility preservation techniques exist to help mitigate this, including freezing eggs, sperm, ovarian tissue or testicular tissue. It recommends that oncologists discuss these options proactively with patients to give them hope for biological children after cancer. Specific techniques are described such as in vitro fertilization with eggs or sperm frozen before treatment. Referral to fertility specialists is advised so patients can explore preservation options before starting cancer treatment.
The Role of laparoscopy in the era of ARTDrRokeyaBegum
The advancement of new perspectives in assisted reproductive technology (ART) through the use of modern infertility evaluation technique Stillclinician needs to reassess how infertility should be best treated.
Recently the focus of treatment for infertility has shifted from systematic correction of each identified factor.
May occur very early on during the attachment or migration stages (No objective evidence e.g. –ve hCG)
May also occur at a later stage (+ve hCG) but process becomes disrupted
Definition: Refers to the failure of the embryo to reach a stage when an intrauterine gestational sac is recognized by ultrasonography.
Implantation failure can apply to patients undergoing ART and patients trying to conceive without any fertility treatment.
It is a separate entity from RPL
Orvieto et al - 3 failed IVF-ET cycles with good quality embryos transferred .
Zeyneloglu et al. - 3 unsuccessful IVF specifically with two embryos of high quality
Simon and Laufer - embryo & endometrium can both play an active role in RIF
Coughlan et al. suggest a more complete working definition taking into account maternal age, number of embryos transferred, and number of cycles completed.
They define RIF as the failure of clinical pregnancy after 4 good quality embryo transfers, with at least three fresh or frozen IVF cycles, and in women under the age of 40
RIF is a complex problem with a wide variety of etiologies / mechanisms/ treatment options.
Recommendations vary depending on the source of their problem. Perhaps the best and yet most complex answer is personalized medicine, a personal approach to each patient depending on her unique set of characteristics.
It would help to establish a set of standardized tests to use, in order to do a preliminary evaluation on each patient, which would then hopefully direct the approach of treatment for each individual couple.
This can be implemented when we have well designed studies that will help us to establish new protocols.
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIDR SHASHWAT JANI
This document discusses the role of progesterone in preventing preterm labor and delivery. It provides information on progesterone's mechanisms of action, guidelines and evidence for its use, and summarizes various studies conducted on oral and vaginal progesterone for reducing preterm birth risks in high-risk groups like women with a short cervix or history of prior preterm delivery. The document also compares micronized progesterone to hydroxyprogesterone caproate in terms of indications and side effects.
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...Apollo Hospitals
The incidence of multiple gestations is increasing with
increasing maternal age and use of assisted reproduction
techniques. Selective fetal reduction of multifetal pregnancies is now widely practiced to reduce the higher order multiples to twins based on evidence from nonrandomised studies which suggests that this will improve the perinatal outcome. The proportion of twin pregnancies with unique fetal and maternal problems is therefore increasing. Optimising maternal, fetal and perinatal outcomes in twin pregnancies continues to be a formidable challenge in the present day clinical practice.
The document discusses preterm birth rates in the United States, risks of preterm birth for infants, and potential causes and predictors of preterm birth. It also reviews various interventions for preventing preterm birth, including cervical cerclage, tocolytic medications, progesterone supplementation, and cervical length screening.
This document provides information on preterm and post-term labor. It defines preterm labor as onset of labor before 37 weeks of gestation and discusses the main risk factors, diagnosis, and management. Diagnosis requires documentation of regular contractions and cervical changes. Tocolytics and steroids are used to delay delivery. For post-term labor, it defines this as pregnancy exceeding 42 weeks and notes the risks include macrosomia, dystocia, and complications of prolonged labor. Conservative management or induction is recommended depending on cervical status and fetal well-being.
Slideshow on Unexplained infertility presented in 2009 - treatment options, diagnosis and more. Assisted reproductive technologies and its details
Discussion of IUI, IVF and other infertility treatment options
O&G PRETERM DELIVERY, Tutorial for 2024 v1getplaye
The document discusses preterm birth, defined as birth occurring between 20 and 37 weeks of gestation. Some key points:
- Globally in 2020, about 13.4 million babies (10% of births) were born preterm. Risks of mortality and morbidity increase with lower gestational ages.
- Ireland's preterm birth rate in 2020 was 7%, up from 6% in 2011. The perinatal mortality rate is much higher for preterm (<37 weeks) births compared to term births.
- Major risk factors for preterm birth include previous preterm delivery, multiple pregnancies, and cervical length less than 25mm on ultrasound between 16-24 weeks.
- Prevention strategies include
Dr. Kirtan Vyas is an assistant professor who has numerous qualifications and accomplishments. He has published in international journals, presented at conferences, and held various organizational roles. The document discusses preterm labor (PTL), defining it as labor before 37 weeks of pregnancy. It outlines the significance and risk factors of PTL and describes the initial evaluation, management, and potential neonatal complications of PTL. Evaluation includes examination, ultrasound, and biochemical markers to assess the status of the cervix and predict the likelihood of preterm delivery."
Prenatal diagnosis refers to the testing and diagnosis of a fetus during pregnancy. The goal of prenatal diagnosis is to identify any potential genetic or chromosomal abnormalities, structural defects, or other conditions that may affect the health of the fetus or the pregnancy.
There are several types of prenatal diagnostic tests that can be used, including:
Chromosomal analysis: This test can detect chromosomal abnormalities such as Down syndrome, Turner syndrome, and others. The most common method is chorionic villus sampling (CVS) done between 10-12 weeks of pregnancy, and amniocentesis done between 15-20 weeks of pregnancy.
Ultrasound: This is a non-invasive test that uses high-frequency sound waves to create images of the fetus and placenta. It can detect structural defects such as cleft lip, neural tube defects, and other problems.
Cell-free DNA testing: This is a non-invasive test that analyzes small fragments of DNA from the placenta that are present in the mother's blood. It can detect chromosomal abnormalities such as Down syndrome and Trisomy 13, 18, and 21.
Maternal serum screening: This is a blood test that measures certain proteins and hormones in the mother's blood. It can detect certain chromosomal and genetic conditions such as Down syndrome, Trisomy 18 and 13, and neural tube defects.
It's important to note that prenatal diagnosis is a personal decision and should be made after a discussion of the risks, benefits, and limitations of the test with the healthcare provider. The results of prenatal diagnostic testing can have significant emotional, social, and medical implications, and genetic counseling is recommended before and after the test to help families make informed decisions.
This document discusses preventing preterm labour. It begins by providing statistics on the incidence of preterm birth in various locations. It then discusses the magnitude of the problem, highlighting the high costs of preterm birth. Several studies on outcomes of extremely preterm infants are summarized. The document is then organized into sections on primary, secondary, and tertiary prevention of preterm labour. Key points are made about various risk factors and diagnostic tools, as well as treatments such as progesterone, cerclage and antibiotics.
Screening for and treatment of asymptomatic bacteriuria in high-risk pregnant women reduces the risk of preterm birth. However, routine screening of all pregnant women in the first trimester with urine culture is not currently recommended due to the low prevalence of asymptomatic bacteriuria in the general pregnant population and the costs of universal screening.
This document discusses preterm labor, including a case study. It defines preterm labor as occurring between 24-37 weeks gestation. Epidemiology shows that 12% of deliveries are preterm. Risk factors include previous preterm birth, infections, and smoking. Diagnosis involves assessing contractions and cervical changes. Complications of prematurity include respiratory distress and intraventricular hemorrhage. Management goals are to delay delivery for steroid administration and transport to facilities with NICU capabilities using tocolysis like nifedipine. Prevention strategies have not proven consistently effective.
The document discusses tuberculosis and its impact on in vitro fertilization (IVF) outcomes. It addresses several questions:
1) There are differences in IVF success rates between phenotypes of tuberculosis, with subclinical TB having higher success than clinical TB. Treated pulmonary TB has similar outcomes to non-TB patients.
2) IVF success rates in TB have improved over time and are now comparable to other causes of infertility as TB incidence decreases.
3) TB, even subclinical TB, negatively impacts ovarian reserve. Ovarian function improves after antituberculosis treatment.
4) For hydrosalpinges in genital TB, bilateral salpingectomy followed by antituberculosis treatment is recommended
Preterm Labour and Premature Rupture of Membranes Mob: 7289915430, www.drprad...Pradeep Garg
The document summarizes information on preterm labor and premature rupture of membranes. It defines preterm labor as regular contractions before 37 weeks of gestation that are associated with cervical changes. It notes the incidence of preterm labor is 8-10% and discusses definitions, magnitude, causes, risk factors, signs and symptoms, biological markers, cervical length screening, infections associated with preterm labor, and treatments including tocolytics and antenatal corticosteroids.
This document discusses recurrent miscarriage, providing definitions and epidemiology. It defines recurrent miscarriage as 3 or more consecutive miscarriages. Causes discussed include polycystic ovary syndrome, antiphospholipid syndrome, chromosomal abnormalities, endocrine disorders, and uterine abnormalities. Investigation and management strategies are presented for different potential causes. For unexplained recurrent miscarriage, progesterone and aspirin are discussed but evidence for their effectiveness is limited. Counseling and lifestyle modifications are recommended.
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...Lifecare Centre
OUTLINE….of RM
* KNOWN KNOWNWhat we know & we DO: **KNOWN UNKNOWNWhat we know but do not do: ***UNKNOWN KNOWNWhat we know that we do not know ****UNKNOWN UNKNOWNTOTALLY NEW .. Future
This document discusses obesity, gestational diabetes, and pregnancy outcomes. It reports that maternal obesity has a stronger influence on childhood obesity in offspring than gestational diabetes alone. Obesity and gestational diabetes have synergistic effects in increasing risks during pregnancy like macrosomia and cesarean section. Screening and treatment of gestational diabetes improves neonatal outcomes, but maternal obesity remains the main risk factor to address.
The document summarizes newborn screening statistics in Kuwait for 2015. It provides data on the number of babies screened, diseases tested for, screening results, and screening performance indicators. In 2015, over 52,000 newborn screening samples were received and analyzed. Of those, 1,595 samples were identified as high risk, and further testing confirmed 114 babies were affected by various treatable conditions. The screening program successfully helped identify and treat affected newborns in a timely manner to prevent health issues.
This document summarizes information on preterm birth (PTB) and the use of progesterone supplementation to prevent PTB. It begins by defining PTB as birth before 37 weeks gestation. It then discusses risk factors for PTB like previous preterm births, infections, cervical factors. It describes evaluating cervical length via transvaginal ultrasound to predict risk. Progesterone supplementation options are discussed including various formulations and 17-alpha hydroxyprogesterone caproate injections. The document summarizes evidence that progesterone reduces rates of preterm birth and improves neonatal outcomes.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Tests for analysis of different pharmaceutical.pptx
Selective embryo-fetal reduction
1. The Fetal Medicine
Foundation
Sofía Fournier
Margarita Torrents
Cayetana Barbed
Mónica Echevarría
Mina Comas
MARBELLA, JUNE 2013
SELECTIVE EMBRYO-FETAL REDUCTION.
OUR EXPERIENCE OVER THE LAST 20 YEARS
FACTORS AFFECTING OUTCOME
HOSPITAL UNIVERSITARIO QUIRÓN DEXEUS, BARCELONA. SPAIN
0%
10%
20%
30%
40%
50%
60%
<37
weeks
< 34
weeks
< 32
weeks
congenital defect
multiple pregnancy
N: 177
From 1989 to 2011
2. The Fetal Medicine
Foundation
Selective embryo-fetal reduction.
Factors affecting outcome
Objective:
To analyze our own results in selective embryo-fetal reductions during a 22-year
period, focusing on percentage of fetal loss and prematurity rate
Material and methods:
177 embryo-fetal reductions performed from 1989 to
2011
149 cases with a complete follow-up (84,2%)
Indications:
64,9% multiple pregnancy
35,02% congenital defect
Only one operator performing all the cases
Introduction:
Indications for a selective embryo-fetal reduction in our hospital:
-High order multiple pregnancies (>3) or triplets in high-risk patients
-Congenital defect in one of the embryos/fetuses
3. The Fetal Medicine
Foundation
Results: Fetal loss according to:
Selective embryo-fetal reduction.
Factors affecting outcome
P: 0,59 P: 0,77
P: 0,23
No significant relationship with
GA.
Higher risk <10th week: linked
to cases performed during the
initial period (higher number of
embryos to reduce and less
experience).
Trend higher risk >12th week
No significant relationship with
the initial number of fetuses (trend
to increased risk when > 3 fetuses)
No significant relationship with
the number of fetuses reduced
(trend to increased risk when >1
fetus)
GA procedure Initial n fetuses n fetuses reduced
4. The Fetal Medicine
Foundation
Results:
Selective embryo-fetal reduction.
Factors affecting outcome
INDICATION OVERALL
CONGENITAL
DEFECT
MULTIPLE
PREGNANCY
NOT COMPLETE
INFORMATION
13
21%
15
13%
28
15,8%
FETAL LOSS
5
8,1%
12
10,4%
17
9,6%
< 37 WEEKS
9
14,5%
49
42,6%
58
32,8%
>37 WEEKS
35
56,5%
39
33,9%
74
41,8%
OVERALL
62
35,02%
115
64,9%
177
100%
Overall fetal loss rate: 9,6%
8,1% when congenital defect
10,4% when multiple pregnancy
Overall prematurity rate: 32,8%
14,5% in the congenital defect group
42,6% in the multiple pregnancy group
P < 0,05
0%
10%
20%
30%
40%
50%
60%
multiple pregnancy
congenital defect
P>0,05
Learning curve
% fetal loss
5. The Fetal Medicine
Foundation
Conclusions
Thank you
Selective embryo-fetal reduction.
Factors affecting outcome
11%
Indication for selective embryo-fetal reduction has significantly changed:
Multiple pregnancies in high-risk patients used to be the most frequent
Congenital defects is the most frequent indication nowadays
The overall perinatal result is worse in cases due to multiple pregnancy,
with a higher rate of fetal loss and prematurity.
No significant relationship with GA, initial number of fetuses nor number
of fetuses reduced
Trend to increased risk when >12 weeks (importance of earlier diagnosis)
Trend to increased risk when >3 initial fetuses
Trend to increase when >1 fetus reduced
Performing the technique by expert hands with an appropriate learning curve
guarantees better perinatal results.
Editor's Notes
Hello, my name is Sofia Fournier. I come from Barcelona and I’m going to talk about our series in selecive embryo-fetal reductions. We have been performing this technique since 1989, and I will focus on the factor affecting pregnancy outcome.
In our hospital the indications for practising this technique are: when we have a high order multiple pregnancy, which was something quite frequent in the beggining due to initial reproductive assisted techniques, in cases of triplets in high risk patients or in twins with a congenital defect in one of the embryos or fetuses. Usually in the firs case the reduction is performed before than in the case of a congenital defect in one of the twins. The aim of our study is to analyze our own results during a 22 year period, focusing on percentage of fetal loss and prematurity rate.
We have performed 177 embryo-fetal reductions in our feto-maternal unit, from 1989 to 2011. We have a complete follow up of 149 cases. And depending on the indication, we have 65% of cases due to multiple pregnancy and 35% due to congenital defect. Only one operator performed all the techniques.
We have a long serie of cases, not only for the number of cases but as well for the long period of time, and that’s been a factor affecting on our possibilities of collecting all the information. Nevertheless we have been able to find out some factors affecting the outcome: the gestational age in which we perform the technique, the initial number of fetuses and the number of fetuses reduced. We did not find a significant relationship with any of those factors, but if we analyze the results in function of the gestational age wue can see that the higher risk in performing the reduction before the 10th week is linked to those cases performed during the initial period, when there were more embryos to reduce and less experience. And excluding that fact we can see a trend in having more risk when performing it after the 12th week. In the case of the initial number of fetuses, we also can see an increase of risk when it is more than 3 embryos. And finally if we take into account the number of fetus reduced, we also see a trend to an increased risk when we reduce more than one fetus.
When we analyze the results depending on the main indication we can see that the fetal loss rate is very similar in both groups but not the overall prematurity rate, which is significantly higher in the multiple pregnancy group, as expected. The numbers of overall prematurity are in the case of multiple pregnancy very similar to our multiple pregnancies that haven’t undergone a reduction, but when we take a look at prematurity before 34 or 32 weeks is quite higher in the reduced group that in normal twin pregnancies (15% and 7% in reduced pregnancies and 6% and 5% in the normal ones). If we compare the pregnancies that have undergone a reduction of a fetus with a congenital defect and then continue to be singletone pregnancies, the rate of prematurity is higher than our rate of prematurity in singletons, that is around 5%.
And finally, taking advantage of the fact that all the reductions in our hospital have been performed mainly by one operator we have analyzed the effect that the learning curve can have in the outcome. Although the results have no statistical significance, we have found a reduction in the percentage of fetal loss from the beggining till nowadays.
And just to conclude, i would like to say that the indication for selective embryofetal reduction in our hospital has clearly changed with the years, being multiple pregnancies the main reason in the beggining and congenital defects in twin pregnancies the most frequent indication nowadays.
The overall perinatal result is worse in cases due to multiple pregnancy, as expected, with a higher rate of fetal loss and prematurity.
That even if there is no significant relationship with the gestational age in which performing the technique, the initial number of fetuses nor the number of fetuses reduced, we have found a trend to increased risk if performing the technique after the 12th week of pregnancy ( so that’s why first trimestre diagnosis), if the initial number of fetuses is higher than 3 or if we have to reduce more than one fetus.
Finally, we can conclude that performing those reductions by expert hands with a good learning curve, the final results will be better.
Thank you very much.